News
Prescient Therapeutics has entered a critical stage where clinical data, regulatory support, and commercial potential begin ...
Abivax dazzled investors and analysts with positive data from a pair of Phase III induction trials assessing obefazimod in adults with moderately to severely active ulcerative colitis. The results ...
The ADAM contraceptive is a hydrogel injected into the male sperm ducts to block the passage of sperm, and it seems to still ...
A clinical study shows that pterostilbene, a natural compound, significantly improves signs of aging in the skin, pointing to a new direction in skincare science. As interest in anti-aging skincare ...
New clinical trials are advancing treatments for cutaneous T-cell lymphoma, advanced solid tumors, pediatric sarcomas and ALK ...
The trial will test several treatment approaches in the maintenance setting for extensive stage small cell lung cancer.
SAP-001 is an investigational oral agent designed to reduce serum uric acid levels by targeting a distinct renal urate reabsorption transporter.
Context Therapeutics Inc. (NASDAQ: CNTX) is one of the best penny stocks under $1 to buy now. Earlier in June, Context ...
SE (NASDAQ:ARGX) is one of the Best Extremely Profitable Stocks to Buy Right Now. On June 30, argenx SE (NASDAQ:ARGX) ...
2d
Zacks Investment Research on MSNRXRX vs. RLAY: Which Precision Biotech Stock is a Better Bet Now?
Recursion Pharmaceuticals RXRX and Relay Therapeutics RLAY are pioneering the use of artificial intelligence (AI) in drug ...
Topline data were announced from a phase 3 clinical program evaluating anselamimab in patients with Mayo stages 3a and 3b light chain (AL) amyloidosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results